Form 8-K - Current report:
SEC Accession No. 0001193125-26-296710
Filing Date
2026-07-07
Accepted
2026-07-06 21:55:41
Documents
29
Period of Report
2026-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d113650d8k.htm   iXBRL 8-K 50492
2 EX-99.1 d113650dex991.htm EX-99.1 29543
6 GRAPHIC g113650ex99_1p10g1.jpg GRAPHIC 368810
7 GRAPHIC g113650ex99_1p11g1.jpg GRAPHIC 429019
8 GRAPHIC g113650ex99_1p12g1.jpg GRAPHIC 372893
9 GRAPHIC g113650ex99_1p13g1.jpg GRAPHIC 368142
10 GRAPHIC g113650ex99_1p14g1.jpg GRAPHIC 364487
11 GRAPHIC g113650ex99_1p15g1.jpg GRAPHIC 400189
12 GRAPHIC g113650ex99_1p16g1.jpg GRAPHIC 284088
13 GRAPHIC g113650ex99_1p17g1.jpg GRAPHIC 395246
14 GRAPHIC g113650ex99_1p1g1.jpg GRAPHIC 335951
15 GRAPHIC g113650ex99_1p2g1.jpg GRAPHIC 951805
16 GRAPHIC g113650ex99_1p3g1.jpg GRAPHIC 395215
17 GRAPHIC g113650ex99_1p4g1.jpg GRAPHIC 387990
18 GRAPHIC g113650ex99_1p5g1.jpg GRAPHIC 283738
19 GRAPHIC g113650ex99_1p6g1.jpg GRAPHIC 451171
20 GRAPHIC g113650ex99_1p7g1.jpg GRAPHIC 376271
21 GRAPHIC g113650ex99_1p8g1.jpg GRAPHIC 296318
22 GRAPHIC g113650ex99_1p9g1.jpg GRAPHIC 417005
  Complete submission text file 0001193125-26-296710.txt   9686461

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrtx-20260706.xsd EX-101.SCH 3167
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrtx-20260706_lab.xml EX-101.LAB 17232
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrtx-20260706_pre.xml EX-101.PRE 10803
33 EXTRACTED XBRL INSTANCE DOCUMENT d113650d8k_htm.xml XML 3541
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 261157731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)